Cargando…

Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia

Chronic lymphocytic leukaemia is the most prevalent leukaemia in Western countries. It is an incurable disease characterized by a highly variable clinical course. Chronic lymphocytic leukaemia is an ideal model for studying clonal heterogeneity and dynamics during cancer progression, response to the...

Descripción completa

Detalles Bibliográficos
Autores principales: González-Rincón, Julia, Gómez, Sagrario, Martinez, Nerea, Troulé, Kevin, Perales-Patón, Javier, Derdak, Sophia, Beltrán, Sergi, Fernández-Cuevas, Belén, Pérez-Sanz, Nuria, Nova-Gurumeta, Sara, Gut, Ivo, Al-Shahrour, Fátima, Piris, Miguel A., García-Marco, José A., Sánchez-Beato, Margarita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353992/
https://www.ncbi.nlm.nih.gov/pubmed/30700761
http://dx.doi.org/10.1038/s41598-018-37389-7
_version_ 1783391082008018944
author González-Rincón, Julia
Gómez, Sagrario
Martinez, Nerea
Troulé, Kevin
Perales-Patón, Javier
Derdak, Sophia
Beltrán, Sergi
Fernández-Cuevas, Belén
Pérez-Sanz, Nuria
Nova-Gurumeta, Sara
Gut, Ivo
Al-Shahrour, Fátima
Piris, Miguel A.
García-Marco, José A.
Sánchez-Beato, Margarita
author_facet González-Rincón, Julia
Gómez, Sagrario
Martinez, Nerea
Troulé, Kevin
Perales-Patón, Javier
Derdak, Sophia
Beltrán, Sergi
Fernández-Cuevas, Belén
Pérez-Sanz, Nuria
Nova-Gurumeta, Sara
Gut, Ivo
Al-Shahrour, Fátima
Piris, Miguel A.
García-Marco, José A.
Sánchez-Beato, Margarita
author_sort González-Rincón, Julia
collection PubMed
description Chronic lymphocytic leukaemia is the most prevalent leukaemia in Western countries. It is an incurable disease characterized by a highly variable clinical course. Chronic lymphocytic leukaemia is an ideal model for studying clonal heterogeneity and dynamics during cancer progression, response to therapy and/or relapse because the disease usually develops over several years. Here we report an analysis by deep sequencing of sequential samples taken at different times from the affected organs of two patients with 12- and 7-year disease courses, respectively. One of the patients followed a linear pattern of clonal evolution, acquiring and selecting new mutations in response to salvage therapy and/or allogeneic transplantation, while the other suffered loss of cellular tumoral clones during progression and histological transformation.
format Online
Article
Text
id pubmed-6353992
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63539922019-02-01 Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia González-Rincón, Julia Gómez, Sagrario Martinez, Nerea Troulé, Kevin Perales-Patón, Javier Derdak, Sophia Beltrán, Sergi Fernández-Cuevas, Belén Pérez-Sanz, Nuria Nova-Gurumeta, Sara Gut, Ivo Al-Shahrour, Fátima Piris, Miguel A. García-Marco, José A. Sánchez-Beato, Margarita Sci Rep Article Chronic lymphocytic leukaemia is the most prevalent leukaemia in Western countries. It is an incurable disease characterized by a highly variable clinical course. Chronic lymphocytic leukaemia is an ideal model for studying clonal heterogeneity and dynamics during cancer progression, response to therapy and/or relapse because the disease usually develops over several years. Here we report an analysis by deep sequencing of sequential samples taken at different times from the affected organs of two patients with 12- and 7-year disease courses, respectively. One of the patients followed a linear pattern of clonal evolution, acquiring and selecting new mutations in response to salvage therapy and/or allogeneic transplantation, while the other suffered loss of cellular tumoral clones during progression and histological transformation. Nature Publishing Group UK 2019-01-30 /pmc/articles/PMC6353992/ /pubmed/30700761 http://dx.doi.org/10.1038/s41598-018-37389-7 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
González-Rincón, Julia
Gómez, Sagrario
Martinez, Nerea
Troulé, Kevin
Perales-Patón, Javier
Derdak, Sophia
Beltrán, Sergi
Fernández-Cuevas, Belén
Pérez-Sanz, Nuria
Nova-Gurumeta, Sara
Gut, Ivo
Al-Shahrour, Fátima
Piris, Miguel A.
García-Marco, José A.
Sánchez-Beato, Margarita
Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
title Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
title_full Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
title_fullStr Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
title_full_unstemmed Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
title_short Clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
title_sort clonal dynamics monitoring during clinical evolution in chronic lymphocytic leukaemia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353992/
https://www.ncbi.nlm.nih.gov/pubmed/30700761
http://dx.doi.org/10.1038/s41598-018-37389-7
work_keys_str_mv AT gonzalezrinconjulia clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT gomezsagrario clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT martineznerea clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT troulekevin clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT peralespatonjavier clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT derdaksophia clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT beltransergi clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT fernandezcuevasbelen clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT perezsanznuria clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT novagurumetasara clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT gutivo clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT alshahrourfatima clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT pirismiguela clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT garciamarcojosea clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia
AT sanchezbeatomargarita clonaldynamicsmonitoringduringclinicalevolutioninchroniclymphocyticleukaemia